Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 8, 2025 • 12:00 AM ET

Date/Time Source News Release
06/25/2025 08:30 AM EDT Business Wire Vistagen Appoints Elissa Cote as Chief Corporate Development Officer
06/17/2025 04:30 PM EDT Business Wire Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
06/12/2025 08:30 AM EDT Business Wire Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
06/02/2025 08:30 AM EDT Business Wire Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
05/28/2025 08:30 AM EDT Business Wire Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York
05/23/2025 08:30 AM EDT Business Wire Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference
04/17/2025 08:30 AM EDT Business Wire Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference
03/19/2025 08:30 AM EDT Business Wire Vistagen to Present at the 2025 Anxiety and Depression Association Conference
03/04/2025 08:30 AM EST Business Wire Vistagen to Participate in Stifel 2025 Virtual CNS Forum
02/20/2025 08:30 AM EST Business Wire Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference
Page

Additional News

As of July 8, 2025 • 12:00 AM ET

Date/Time Source News Release
06/17/2025 06:50 PM EDT SeekingAlpha Vistagen targets transformative SAD drug approval with top-line PALISADE-3 data in Q4 2025 while advancing differentiated neuroscience pipeline
06/17/2025 06:49 PM EDT SeekingAlpha Vistagen Therapeutics, Inc. (VTGN) Q4 2025 Earnings Call Transcript
06/17/2025 04:32 PM EDT SeekingAlpha VistaGen Therapeutics GAAP EPS of -$1.67 beats by $0.07, revenue of $0.48M misses by $0.23M
06/17/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
06/17/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, June 17th, 2025
06/17/2025 05:31 AM EDT US Earnings Reports Expected earnings - Vistagen Therapeutics Inc.
06/16/2025 05:35 PM EDT SeekingAlpha VistaGen Therapeutics Q4 2025 Earnings Preview
06/10/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, June 10th, 2025
06/10/2025 05:31 AM EDT US Earnings Reports Expected earnings - Vistagen Therapeutics Inc.
06/09/2025 06:47 PM EDT KlickAnalytics VTGN - Historical Price Movements Surrounding Earnings
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.